U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H21N
Molecular Weight 155.2804
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOPROPYLHEXEDRINE

SMILES

CN[C@@H](C)CC1CCCCC1

InChI

InChIKey=JCRIVQIOJSSCQD-VIFPVBQESA-N
InChI=1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3/t9-/m0/s1

HIDE SMILES / InChI
Molecular Formula C10H21N
Molecular Weight 155.2804
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including, http://toxcenter.org/stoff-infos/l/levopropylhexedrin.pdf

Propylhexedrine Hydrochloride is an α-adrenergic sympathomimetic amine that acts as a local vasoconstrictor. It is the active ingredient in some over-the-counter nasal decongestants, typically by intravenous or oral delivery of the nasal decongestant. Propylhexedrine is known under the brand name Benzedrex. Propylhexedrine has also seen use in Europe as an appetite suppressant under the trade name Obesin and in the anticonvulsant preparation barbexaclone its S-isomer PROPYLHEXEDRINE HYDROCHLORIDE, (-)- (levopropylhexedrine or L-propylhexedrine) is bonded with phenobarbital for the purpose of offsetting the barbiturate-induced sedation. Levopropylhexedrine is also used as an anorectic under the brand name Eventin.

CNS Activity

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Agonist
2678
Agonist
2678
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
Eventin

Approved Use

Appetite depressant
Primary
Approved
8429
Benzedrex

Approved Use

Self-medication for temporary relief of nasal congestion associated with the common cold, hay fever, or other allergies.
Primary
Approved
8429
Benzedrex

Approved Use

Self-medication for temporary relief of nasal congestion associated with the common cold, hay fever, or other allergies.
Primary
Approved
8429
Maliasin

Approved Use

Barbexoclone (Maliasin®) is an antiepileptic drug, which has been found to be effective in the treatment of epilepsy.

Launch Date

1983
Curative
Withdrawn
Eventin

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.5 μg/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/6139756/
66 mg/kg 1 times / day steady-state, oral
dose: 66 mg/kg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: PHENOBARBITAL
PHENOBARBITAL
 PROPYLHEXEDRINE plasma
Mus musculus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1.3 μg × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/6139756/
66 mg/kg 1 times / day steady-state, oral
dose: 66 mg/kg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: PHENOBARBITAL
PHENOBARBITAL
 PROPYLHEXEDRINE plasma
Mus musculus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
2.5 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/6139756/
66 mg/kg 1 times / day steady-state, oral
dose: 66 mg/kg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: PHENOBARBITAL
PHENOBARBITAL
 PROPYLHEXEDRINE plasma
Mus musculus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 17 years
n = 1
Health Status: unknown
Age Group: 17 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 19 years
n = 1
Health Status: unknown
Age Group: 19 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 19 years
n = 1
Health Status: unknown
Age Group: 19 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 22 years
n = 1
Health Status: unknown
Age Group: 22 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death, Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 23 years
n = 1
Health Status: unknown
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 24 years
n = 1
Health Status: unknown
Age Group: 24 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 25 years
n = 1
Health Status: unknown
Age Group: 25 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
180 mg 1 times / day steady, oral
Studied dose
Dose: 180 mg, 1 times / day
Route: oral
Route: steady
Dose: 180 mg, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/3709618/
healthy, 25-37 years
n = 7
Health Status: healthy
Age Group: 25-37 years
Sex: M
Population Size: 7
Sources:
https://pubmed.ncbi.nlm.nih.gov/3709618/
Sources:
https://pubmed.ncbi.nlm.nih.gov/3709618/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 26 years
n = 1
Health Status: unknown
Age Group: 26 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 27 years
n = 1
Health Status: unknown
Age Group: 27 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death, Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 28 years
n = 1
Health Status: unknown
Age Group: 28 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 29 years
n = 1
Health Status: unknown
Age Group: 29 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death, Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 34 years
n = 1
Health Status: unknown
Age Group: 34 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Disc. AE: Death...
AEs leading to
discontinuation/dose reduction:
Death (grade 5)
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
AEs

AEs

AESignificanceDosePopulation
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 17 years
n = 1
Health Status: unknown
Age Group: 17 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 19 years
n = 1
Health Status: unknown
Age Group: 19 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 19 years
n = 1
Health Status: unknown
Age Group: 19 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 22 years
n = 1
Health Status: unknown
Age Group: 22 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 22 years
n = 1
Health Status: unknown
Age Group: 22 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 23 years
n = 1
Health Status: unknown
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 24 years
n = 1
Health Status: unknown
Age Group: 24 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 25 years
n = 1
Health Status: unknown
Age Group: 25 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 26 years
n = 1
Health Status: unknown
Age Group: 26 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 27 years
n = 1
Health Status: unknown
Age Group: 27 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 27 years
n = 1
Health Status: unknown
Age Group: 27 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 28 years
n = 1
Health Status: unknown
Age Group: 28 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 29 years
n = 1
Health Status: unknown
Age Group: 29 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 29 years
n = 1
Health Status: unknown
Age Group: 29 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Death grade 5
Disc. AE
250 mg single, intravenous
Abused dose
Dose: 250 mg
Route: intravenous
Route: single
Dose: 250 mg
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
unknown, 34 years
n = 1
Health Status: unknown
Age Group: 34 years
Sex: F
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/37732/
Sourcing

Sourcing

Vendor/AggregatorIDURL
1PlusChem LLC
1P000345
ABI Chem
AC1L1P1A
AK Scientific
0377AA
Alfa Chemistry
101-40-6
https://www.alfa-chemistry.com/n-alpha-dimethylcyclohexaneethylamine-cas-101-40-6-item-289407.htm
Ambinter
Amb1098803
http://www.ambinter.com/reference/1098803
Aurum Pharmatech LLC
W-6202
http://www.Aurumpharmatech.com/Product/ProductDetails/W_6202
BOC Sciences
101-40-6
BioBlocks
A4312/0184095
BlocksMatrix Scientific
60201
Cayman Chemical
12058
ChemBridge
3001688
ChemDiv
8019-4095
Chemieliva Pharmaceutical Co., Ltd
PBCM0019750
Chemspace
CSSS00011712502
https://chem-space.com/CSSS00011712502
Compound Cloud
102541
Compound Cloud
71197
Compound Cloud
7558
Enamine
BBV-34542029
Enamine
BBV-38278530
Enamine
BBV-39951695
Finetech
FT-0674106
http://www.finetechnology-ind.com/prod/detail/pub/1007-33-6.html
Fluorochem
70282
Hangzhou Yuhao Chemical Technology
RT3982
HongKong Chemhere
SCE08368
Lab Network
LN00160712
Lan Pharmatech
LQT-B08815
MuseChem
R052098
NCI Plated 2007
170998
NCI Plated 2007
27110
Norris Pharm
NSZB-A047461
NovoSeek
7558
Princeton BioMolecular Research
OSSL_312908
Princeton BioMolecular Research
OSSL_782547
Princeton BioMolecular Research
PBMR122742
Scientific Exchange
F-394417
Smolecule
S600732
https://www.smolecule.com/products/s600732
TimTec
ST4139488
http://www.echemstore.com/st4139488-2-cyclohexyl-isopropyl-methylamine.html
Toronto Research Chemicals
C992655
Toronto Research Chemicals
P837150
Vitas-M Laboratory
STK664138
Wonderchem
WD04JUW
ZINC
ZINC000001481910
http://zinc15.docking.org/substances/ZINC000001481910
ZINC
ZINC000001482094
http://zinc15.docking.org/substances/ZINC000001482094
Zelinsky Institute
UZI/2661800
eMolecules
300862979
eMolecules
36552245
eMolecules
42854733
eMolecules
981704
mcule
MCULE-7865947392
https://mcule.com/MCULE-7865947392/
PubMed

PubMed

TitleDatePubMed
[Therapeutic experiences with the appetite depressant eventin].
1958 Apr 5
A comparison of the anticonvulsant properties of l-propylhexedrine, phenobarbital and a salt-like complex of l-propylhexedrine and phenobarbital in mice and rats.
1967 Dec
[L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
1974 May-Jun
Intravenous abuse of propylhexedrine.
1977 Jan
Intravenous prophylhexedrine (Benzedrex®) abuse and sudden death.
1979 Jul
Patents

Patents

US2005002865
3
US2016199305
3
US2454746
4
US7129378
2

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:06:06 GMT 2023
Edited
by admin
on Fri Dec 15 16:06:06 GMT 2023
Record UNII
4R3L4TYV09
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEVOPROPYLHEXEDRINE
INN   WHO-DD  
INN  
Official Name English
levopropylhexedrine [INN]
Common Name English
L-PROPYLHEXEDRINE
Common Name English
L-1-CYCLOHEXYL-2-METHYLAMINOPROPANE
Common Name English
Levopropylhexedrine [WHO-DD]
Common Name English
EVENTIN
Brand Name English
PROPYLHEXEDRINE L-FORM [MI]
Common Name English
(-)-N,.ALPHA.-DIMETHYLCYCLOHEXANEETHYLAMINE
Systematic Name English
PROPYLHEXEDRINE, (S)-
Common Name English
(-)-PROPYLHEXEDRINE
Common Name English
CYCLOHEXANEETHANAMINE, N,.ALPHA.-DIMETHYL-, (.ALPHA.S)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29709
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
Code System Code Type Description
WIKIPEDIA
Levopropylhexedrine
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
CAS
53690-40-7
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
SUPERSEDED
CAS
50453-50-4
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
SUPERSEDED
SMS_ID
100000082282
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
EPA CompTox
DTXSID801024267
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
NCI_THESAURUS
C83883
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
FDA UNII
4R3L4TYV09
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
MERCK INDEX
m9242
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY Merck Index
ChEMBL
CHEMBL2105014
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
ECHA (EC/EINECS)
228-245-0
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
CAS
42870-71-3
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
SUPERSEDED
EVMPD
SUB08487MIG
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
CAS
6192-97-8
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
INN
4279
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
PUBCHEM
71197
Created by admin on Fri Dec 15 16:06:06 GMT 2023 , Edited by admin on Fri Dec 15 16:06:06 GMT 2023
PRIMARY
Related Record Type Details
Structure of BARBEXACLONE
SALT/SOLVATE -> PARENT
Structure of PROPYLHEXEDRINE
RACEMATE -> ENANTIOMER
Related Record Type Details
Structure of LEVOPROPYLHEXEDRINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966